Ally Bridge Group NY LLC Invests $4.40 Million in Arcutis Biotherapeutics, Inc. $ARQT

Ally Bridge Group NY LLC bought a new position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 233,220 shares of the company's stock, valued at approximately $4,396,000. Arcutis Biotherapeutics accounts for approximately 2.7%